Advertisement

Topics

Chroma Therapies Company Profile

18:39 EDT 22nd June 2018 | BioPortfolio


News Articles [183 Associated News Articles listed on BioPortfolio]

Chroma Therapeutics’ Deal with GlaxoSmithKline

At the BIA Leadership Summit, Dr Fintan Walton spoke to Ian Nicholson, CEO of Chroma Therapeutics. They discussed: • Chroma’s deal with GSK • the key to Chroma’s novel chemistry platform tech...

Ian Nicholson of Chroma Therapeutics discusses their recent deal with CTI

In this episode of PharmaTelevision News Review, Fintan Walton talks to Ian Nicholson, CEO at Chroma Therapeutics

Chris Bryant MP Set to Speak at Chroma Therapies’ Acquired Brain Injury Conference

Chair of the All Party Parliamentary Group for Acquired Brain Injury (ABI), Chris Bryant MP, will formally open the Acquired Brain Injury conference, hosted by Chroma, the UK’s ...

Opportunity remains in oncology for gene therapies, says GlobalData

Small pharma leads the way in cancer gene therapies Gene therapies combine reduced treatment duration with a higher chance of...Read More... The post Opportunity remains in oncology for gene therapies...

Gene Therapies are Proving their Worth, but with Million Dollar Price Tags, it’s not Clear Who should Pay for Them

Sterghios Moschos, Associate Professor in Cellular and Molecular Sciences at Northumbria University discusses the benefits of gene therapies and the financial implications of treatments. If you were b...

Chroma Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27022018] Prices from USD $250

SummaryChroma Therapeutics Ltd Chroma Therapeutics is a biotechnology company that discovers and develops small molecule drugs based on chromatin biology and novel cell accumulation approaches. The co...

In a bid to promote stem cell therapies, health officials open a new door for promising contenders

At a time when there’s significant hype around stem cell therapies, the FDA is moving to promote therapies that show the greatest potential.

FDA Sets Path for Stem Cell Therapies

(CNN) – Just months after the US Food and Drug Administration announced efforts to crack down on stem cell clinics touting unapproved therapies, the agency now plans to help expedite the develop...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Hepsera [Excella GmbH]

These highlights do not include all the information needed to use HEPSERA safely and effectively. See full prescribing information for HEPSERA. HEPSERA (adefovir dipivoxil) tablet for oral use Initia...

Hepsera [Gilead Sciences, Inc.]

These highlights do not include all the information needed to use HEPSERA safely and effectively. See full prescribing information for HEPSERA. HEPSERA (adefovir dipivoxil) tablet for oral use Initia...

Olay total effects uv moisturizer [Procter & Gamble Manufacturing Company]

OLAY total effects

PubMed Articles [538 Associated PubMed Articles listed on BioPortfolio]

Efficacy of Pain Relief in Different Postherpetic Neuralgia Therapies: A Network Meta-Analysis.

Postherpetic neuralgia (PHN) is a nerve pain disease usually controlled by different therapies, i.e., topical therapies, antiepileptics, analgesics, antipsychotics, antidepressants, anti-dementia drug...

A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis.

Systemic immunomodulatory therapies are the principal means of managing non-infectious uveitis. This review aims to explore the current landscape of systemic uveitis treatments, including biologic the...

Funding breakthrough therapies: A systematic review and recommendation.

Advanced therapy medicinal products (ATMPs) are innovative therapies likely associated with high prices. Payers need guidance to create a balance between ensuring patient access to breakthrough therap...

Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies.

The efficacy and safety of non-pharmacological therapies for the treatment of acne vulgaris: A systematic review and best-evidence synthesis.

Acne vulgaris is a multifaceted skin disorder, affecting more than 85% of young individuals worldwide. Pharmacological therapy is not always desirable because of the development of antibiotic resistan...

Clinical Trials [1511 Associated Clinical Trials listed on BioPortfolio]

Randomized Clinical Trial of Occlusal Sealant

This study assessed long-term impact of tooth Eruption Stages (ES) on sealant retention on occlusal surfaces previously coated with intermediary bonding layer and it determined caries inci...

Effect of Complementary and Alternative Medicine on Pain Among Inpatients

The proposed study has 3 aims: 1) quantitatively describe a model for delivering complementary and alternative medicine (CAM) therapies to understand the selection of patients and CAM ther...

A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (CHROMA)

This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study evaluating the efficacy and safety of lampalizumab administered by intravitreal injection...

Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)(COMPLETED)

The purpose of this study is to provide posaconazole compassionate treatment to patients with invasive fungal infections: 1) which are resistant to standard antifungal therapies; 2) for wh...

Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies

This is a 2‑arm, randomized, placebo-controlled, double‑blind, international, multicenter study comparing the efficacy of DCC-2618 to placebo in patients who have received treatment wi...

Companies [842 Associated Companies listed on BioPortfolio]

Chroma Therapies

Chroma Technology Corp

Chroma Technology Corp. is a manufacturer of interference filters for the ultra-violet, visible and near-infrared portions of the spectrum, including bandpass, multiple bandpass, and long and short pa...

Chroma Therapeutics Ltd

Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology. Chroma is the first company to system...

Chroma Technology Corp.

Toler RX Incorporated

TolerRx, Inc. is an emerging biopharmaceutical enterprise specializing in the discovery, development, and commercial launch of a novel class of therapies that induce and/or maintain immunological tole...

More Information about "Chroma Therapies" on BioPortfolio

We have published hundreds of Chroma Therapies news stories on BioPortfolio along with dozens of Chroma Therapies Clinical Trials and PubMed Articles about Chroma Therapies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chroma Therapies Companies in our database. You can also find out about relevant Chroma Therapies Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record